FDA Awards ICON with Project Validating PROs

Published on: February 21, 2017

ICON plc announced that the US FDA has awarded the company with a project validating three Patient Reported Outcomes instruments that will measure clinical endpoints in antibacterial drug trials.

ICON plc announced that the US FDA has awarded the company with a project validating three Patient Reported Outcomes instruments that will measure clinical endpoints in antibacterial drug trials.

Read the full release here